Microbot Medical (MBOT) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
TELA Bio (TELA) has outperformed Microbot Medical (MBOT) over the past year, losing 41.2% versus a loss of 62.8%. Over five years, MBOT leads with a -87.4% price change compared with -94.4% for TELA. Microbot Medical is the larger company by market cap ($45.7 million vs $31.1 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MBOT | TELA |
|---|---|---|
| Share price | $0.68 | $0.6885 |
| Market cap | $45.67M | $31.11M |
| 1-day change | -8.52% | -5.27% |
| YTD return | -66.00% | -41.65% |
| 1-year return | -62.84% | -41.15% |
| 5-year return | -87.43% | -94.37% |
| EPS (TTM) | $-0.27 | $-0.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $80.28M |
| Revenue growth (YoY) | — | +15.84% |
| Net income (latest FY) | $-13.14M | $-38.83M |
| Gross margin | — | 67.69% |
| Operating margin | — | -42.05% |
| Net margin | — | -48.37% |
| 52-week high | $2.86 | $1.50 |
| 52-week low | $0.52 | $0.501 |
| Distance from 52-week high | -76.22% | -54.10% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +830.88% | +202.11% |
| Average volume | 922.53K | 217.44K |
| Shares outstanding | 67.16M | 45.19M |
| Employees | 43 | 218 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TELA has outperformed MBOT by 21.7 percentage points over the past year.
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Health Care · Medical/Dental Instruments · 43 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Health Care · Medical/Dental Instruments · 218 employees
MBOT vs TELA FAQ
Which is bigger, Microbot Medical or TELA Bio?
Microbot Medical (MBOT) is larger, with a market capitalization of $45.67M compared with $31.11M for TELA Bio (TELA).
Which stock has performed better over the past year, MBOT or TELA?
TELA returned -41.15% over the past 12 months, compared with -62.84% for MBOT (price return, excluding dividends). Past performance does not predict future results.
Are Microbot Medical and TELA Bio in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.